Stephan A. Grupp

Also affiliated with University of Pennsylvania, Philadelphia University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2024012561

Top 35%

0.563DataRank

Top 35%19 citations

Haesook T. Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng +22 more

Papers

Driven by 34 papers — median percentile 62. Top paper: “In vivo hematopoietic stem cell modification by mRNA delivery”.

In vivo hematopoietic stem cell modification by mRNA delivery

Science(2023)10.1126/science.ade6967

N/A

6.6DataRank · unranked

315 citations

Tyler E. Papp, Michael Triebwasser, Amir Yadegari, Megan T. Fedorky, Naoto Tanaka +12 more

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

Blood Advances(2023)10.1182/bloodadvances.2023009853

N/A

0.794DataRank · unranked

25 citations

Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra +32 more

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

Blood Advances(2022)10.1182/bloodadvances.2022007423

N/A

0.749DataRank · unranked

146 citations

Regina M. Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M. Steinberg +24 more

Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2020)10.1016/j.bbmt.2020.09.008

N/A

0.568DataRank · unranked

7 citations

Angela R. Smith, Nancy A. Kernan, Leslie Lehmann, Robert J. Ryan, Stephan A. Grupp +1 more

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2024012561

Top 35%

0.563DataRank

Top 35%19 citations

Haesook T. Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng +22 more

Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy

Blood Advances(2022)10.1182/bloodadvances.2022008093

N/A

0.533DataRank · unranked

34 citations

Regina M. Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute +17 more

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Blood(2025)10.1182/blood.2024026655

N/A

0.505DataRank · unranked

28 citations

Alexander W. Rankin, Chloe Hoang, Alexandra Semchenkova, Regina M. Myers, Elena Zerkalenkova +76 more

Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents

Blood(2024)10.1182/blood.2024023933

N/A

0.464DataRank · unranked

21 citations

Laura Hernandez-Miyares, Diego A. Espinoza, Brenda L. Banwell, Amit Bar‐Or, Amanda M. DiNofia +12 more

Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry

Blood Advances(2025)10.1182/bloodadvances.2025015881

Top 42%

0.447DataRank

Top 42%18 citations

Kevin J. Curran, Erin Hall, Amy K. Keating, Susanne H.C. Baumeister, Sarah Nikiforow +15 more

A Day 14 Endpoint for Acute GVHD Clinical Trials

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.01.079

N/A

0.373DataRank · unranked

11 citations

Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo‐Hiraldo +36 more

Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell Therapy

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0203

N/A

0DataRank · unranked

58 citations

Amanda DiNofia, David T. Teachey, Stephan A. Grupp, Shannon L. Maude, Kevin O. McNerney

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0822

N/A

0DataRank · unranked

67 citations

Rawan Shraim, Regina M. Myers, Edward M. Behrens, Scott Canna, Hamid Bassiri +21 more

Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells

Nature Reviews Clinical Oncology(2021)10.1038/s41571-020-00456-y

N/A

0DataRank · unranked

68 citations

Juliane Gust, Agne Taraseviciute, Pamela L. Wolters, Allison Barz Leahy, Carlos Sandi +16 more

Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0095

N/A

0DataRank · unranked

9 citations

Chia-Hui Chen, Jessica Perazzelli, Stephan A. Grupp, David M. Barrett, Kai Tan +1 more

Impact of diagnostic and end-of-induction Curie scores in tandem autologous hematopoietic cell transplant for patients with high-risk neuroblastoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10027

N/A

0DataRank · unranked

0 citations

Marguerite T. Parisi, Barry L. Shulkin, Brian LaBarre, Rochelle Bagatell, Lisa Diller +9 more

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy

Blood(2021)10.1182/blood.2021012727

N/A

0DataRank · unranked

115 citations

Kaitlin J. Devine, Yimei Li, Hongyan Liu, Regina M. Myers, Amanda DiNofia +11 more

Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

Blood Advances(2023)10.1182/bloodadvances.2023009885

N/A

0DataRank · unranked

42 citations

Nikolaos Spyrou, William J. Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber +31 more

CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials

The Lancet Haematology(2021)10.1016/s2352-3026(21)00238-6

N/A

0DataRank · unranked

121 citations

Haley Newman, Yimei Li, Hongyan Liu, Regina M. Myers, Amanda DiNofia +11 more

The utility of biomarkers in acute GVHD prognostication

Blood Advances(2023)10.1182/bloodadvances.2023009929

N/A

0DataRank · unranked

18 citations

Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra +29 more

Impact of diagnostic and end‐of‐induction Curie scores with tandem high‐dose chemotherapy and autologous transplants for metastatic high‐risk neuroblastoma: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2023)10.1002/pbc.30418

N/A

0DataRank · unranked

10 citations

Marguerite T. Parisi, Barry L. Shulkin, Brian LaBarre, Rochelle Bagatell, Lisa Diller +9 more

INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.07.016

N/A

0DataRank · unranked

10 citations

Elad Jacoby, Michael A. Pulsipher, Marcelo C. Pasquini, Stephan A. Grupp, Nirali N. Shah +4 more

Data from Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies

(2023)10.1158/1078-0432.c.6532514

N/A

0DataRank · unranked

0 citations

Wei‐Ting Hwang, Shannon L. Maude, David T. Teachey, Noelle V. Frey, Regina M. Myers +6 more

Data from Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing

(2023)10.1158/2326-6066.c.6551154

N/A

0DataRank · unranked

0 citations

Chia-Hui Chen, Jessica Perazzelli, Stephan A. Grupp, David M. Barrett, Kai Tan +1 more

Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL

Journal of Clinical Oncology(2021)10.1200/jco.21.01405

N/A

0DataRank · unranked

206 citations

Agne Taraseviciute, Seth M. Steinberg, Adam J. Lamble, Jennifer Sheppard, Bonnie Yates +23 more

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

Blood Advances(2024)10.1182/bloodadvances.2023012091

N/A

0DataRank · unranked

18 citations

Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo‐Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana +31 more

ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.05.010

N/A

0DataRank · unranked

7 citations

Claire White, Magdi Elsallab, Stephanie Farnia, Ellen Fraint, Bambi Grilley +13 more

Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.08.019

N/A

0DataRank · unranked

2 citations

Muna Qayed, Aaron Etra, Ran Reshef, Richard Newcomb, Nicholas Yuhasz +29 more

INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.04.004

N/A

0DataRank · unranked

1 citations

Vanessa A. Fabrizio, Richard Aplenc, Stephan A. Grupp, Crystal L. Mackall, Robbie G. Majzner +5 more

Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cells

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.16.589780

N/A

0DataRank · unranked

2 citations

Alexandra Neeser, Ranjani Ramasubramanian, Anna Romanov, Ryan Tannir, Naveen K. Mehta +23 more

Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1677

N/A

0DataRank · unranked

207 citations

Changya Chen, Rajat K. Das, Peng Gao, Chia‐Hui Chen, Shovik Bandyopadhyay +9 more

Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells

Nature Biomedical Engineering(2025)10.1038/s41551-025-01470-0

N/A

0DataRank · unranked

3 citations

Alexandra Neeser, Ranjani Ramasubramanian, Anna Romanov, Ryan Tannir, Naveen K. Mehta +23 more

Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States

Frontiers in Immunology(2021)10.3389/fimmu.2021.700374

N/A

0DataRank · unranked

10 citations

Chakkapong Burudpakdee, Stephan A. Grupp, Ulf H. Beier, David M. Barrett, Hamid Bassiri +1 more

Dissecting the Tumor–Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3888

N/A

0DataRank · unranked

27 citations

Andrew Azzam, Yangyang Ding, David M. Barrett, Stephan A. Grupp, Kai Tan +1 more

Distinct bioenergetic features of human invariant natural killer T (iNKT) cells enable retained functions in nutrient-deprived states

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.29.442021

N/A

0DataRank · unranked

0 citations

Chakkapong Burudpakdee, Stephan A. Grupp, Ulf H. Beier, David M. Barrett, Hamid Bassiri +1 more

Stephan A. Grupp

Indexed papers

Top data-sharing exemplar

Papers